Haeger, A.; Soza-Ried, C.; Kramer, V.; Hurtado de Mendoza, A.; Eppard, E.; Emmanuel, N.; Wettlin, J.; Amaral, H.; Fernández, R.
Al[18F]F-NOTA-Octreotide Is Comparable to [68Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumours in the Latin-American Population. Cancers 2023, 15, 439.
https://doi.org/10.3390/cancers15020439
AMA Style
Haeger A, Soza-Ried C, Kramer V, Hurtado de Mendoza A, Eppard E, Emmanuel N, Wettlin J, Amaral H, Fernández R.
Al[18F]F-NOTA-Octreotide Is Comparable to [68Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumours in the Latin-American Population. Cancers. 2023; 15(2):439.
https://doi.org/10.3390/cancers15020439
Chicago/Turabian Style
Haeger, Arlette, Cristian Soza-Ried, Vasko Kramer, Ana Hurtado de Mendoza, Elisabeth Eppard, Noémie Emmanuel, Johanna Wettlin, Horacio Amaral, and René Fernández.
2023. "Al[18F]F-NOTA-Octreotide Is Comparable to [68Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumours in the Latin-American Population" Cancers 15, no. 2: 439.
https://doi.org/10.3390/cancers15020439
APA Style
Haeger, A., Soza-Ried, C., Kramer, V., Hurtado de Mendoza, A., Eppard, E., Emmanuel, N., Wettlin, J., Amaral, H., & Fernández, R.
(2023). Al[18F]F-NOTA-Octreotide Is Comparable to [68Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumours in the Latin-American Population. Cancers, 15(2), 439.
https://doi.org/10.3390/cancers15020439